Top Markets
Coin of the day
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Hisse Senetlerindeki Sıralama #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Hisse Fiyatı
$59.98
Son senkronizasyon: 2024-12-13
Piyasa Değeri
$1.22B
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Longboard Pharmaceuticals, Inc. (LBPH)

Kategori

Longboard Pharmaceuticals, Inc. (LBPH) için EPS
September 2024 itibariyle EPS TTM: $-2.24
Longboard Pharmaceuticals, Inc. şirketinin en son finansal raporlarına ve hisse senedi fiyatına göre, şirketin mevcut EPS'si (TTM) $-2.24'dir. 2022 yılı sonunda, şirketin EPS'si $-2.51 idi; bu, 2021 yılındaki EPS olan $-1.62 ile önceki yıla göre artış.
Longboard Pharmaceuticals, Inc. için 2020 - 2026 arasındaki EPS geçmişi
Her yıl sonunda EPS
Yıl EPS Değiştir
2026 (TTM) $-2.24 -6.28%
2023 $-2.39 -4.78%
2022 $-2.51 54.94%
2021 $-1.62 97.56%
2020 $-0.82 0.00%
Benzer şirketler veya rakipler için EPS
Şirket EPS EPS Farkı Ülke
$17.32 -873.21%
US
$27.74 -1,338.39%
NL
$-5.29 136.16%
AU
$-7.98 256.25%
US
- -
CH